(RTTNews) - UiPath Inc. (PATH) surged 23.79%, climbing $3.54 to $18.40, after announcing its entry into the Veeva AI Partner Program, which will integrate UiPath's automation platform with Veeva's AI-powered testing tools to deliver advanced agentic testing capabilities for life sciences customers.
Investors reacted enthusiastically to the partnership, viewing it as a strategic expansion of UiPath's automation footprint into regulated industries and a potential catalyst for renewed growth in enterprise adoption of its platform.
On the day of the announcement, PATH recorded unusually heavy trading volume as the market digested the partnership news. The stock's 52-week range is approximately $11.05 - $21.50.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
